Breaking down the diabetes silo: Why we need integrated approaches more than ever

The standard of care for diabetes is continuously evolving as new technologies and treatments advance. The market for digital diabetes solutions is already significant at $11.8 billion today and is expected to grow 8.3% annually through 2030 (1).

It’s exciting and more necessary than ever as the CDC now reports that 1 in 6 Americans is living with diabetes (2). The increasing prevalence and risk of associated conditions and health complications will require significantly more support to help manage the potential costs.

It also requires a more serious commitment to treating diabetes with a whole health approach. Already, it is estimated that 1 in 4 dollars spent on health care is associated with diabetes (3). Expanding our approach to diabetes management to emphasize overall health and prevention of potential comorbidities and expensive cost of care will become more critical to help contain costs.

In a company-sponsored retrospective study, Dario recently published data indicating significant savings associated with our Dario’s digital diabetes solution – – an average of $5,077 in medical cost savings for Dario users compared individuals without Dario (4) over the study period. – which reinforces the importance of promoting healthy behaviors to drive more affordable care.

These results are an important finding, but across our large body of research we also believe in expanding our data sets to understand impact beyond diabetes alone. Our members are managing more than diabetes, and we are continuously monitoring our data to better understand what impact we can have on related conditions and behaviors to improve diabetes management.

A sample of some key findings from Dario’s research:

  • Diabetes and GLP-1s: Dario members demonstrate 12 months of sustaining healthier behaviors alongside taking a GLP-1. (5)
  • Diabetes, depression and walking: The monthly average number of steps fully mediates the association between self-reported depression and monthly average BG. (6)
  • Diabetes and hypertension: Members with improvements in their blood pressure readings with Dario also reduced their average blood glucose readings by 15% over 6 months.
  • Diabetes and sleep: Increased levels of deep sleep correlates to significant reductions in blood glucose levels. (8)

There is still much to learn about how diabetes can be better managed in relation to co-occurring conditions, but there is no question that we a whole health approach is the best approach. This Diabetes Awareness Month, we celebrate the progress we’ve made and commit to continuing our research to keep advancing our goal of making it easier for people living with diabetes to achieve better health at a lower cost.

Learn more about the next generation of digital health.

The entire Dario member experience is powered by an intelligent recommendation engine that continuously analyzes clinical and behavioral data to drive sustainable engagement and behavior chang.

Ready to learn more? Schedule a demo with us.

Request a Demo
  1. Digital Diabetes Management Market Size, Share & Trends Analysis Report by product (Continuous Blood Glucose Monitoring System, Smart Insulin PEN), by type, by end-use, by region, and segment Forecasts, 2023 – 2030. (n.d.). https://www.grandviewresearch.com/industry-analysis/digital-diabetes-management-market#:~:text=The%20global%20digital%20diabetes%20management%20market%20size%20was,of%20diabetes%2C%20coupled%20with%20technological%20advancements%20and%20innovations.
  2. Baumblatt, J., Fryar, C., Gu, Q., & Ashman, J. (2024). Prevalence of total, diagnosed, and undiagnosed diabetes in adults: United States, August 2021–August 2023. https://doi.org/10.15620/cdc/165794
  3. Parker, E. D., Lin, J., Mahoney, T., Ume, N., Yang, G., Gabbay, R. A., ElSayed, N. A., & Bannuru, R. R. (2023). Economic costs of diabetes in the U.S. in 2022. Diabetes Care, 47(1), 26–43. https://doi.org/10.2337/dci23-0085
  4. LAURA WILSON, DANIEL C. MALONE, PRAVEEN KUMAR POTUKUCHI, NITA THINGALAYA, KENI C. LEE, ALISON EDWARDS, XINYAN YU, FELIX LEE, ADEE KENNEDY, EDWARD JONATHAN K. HAN-BURGESS, DIANA BRIXNER; 126-LB: Effect of a Digital Diabetes Solution on All-Cause Health Care Resource Utilization Charges for Patients with Type 2 Diabetes—A Retrospective Cohort Study. Diabetes 20 June 2023; 72 (Supplement_1): 126–LB. https://doi.org/10.2337/db23-126-LB
  5. YIFAT HERSHCOVITZ, INBAR BREUER ASHER, OMAR MANEJWALA; 685-P: Digital Platform Users Taking GLP-1 and Managing Diabetes Adapt Lifestyle Behavior Change over Twelve Months. Diabetes 14 June 2024; 73 (Supplement_1): 685–P. https://doi.org/10.2337/db24-685-P
  6. Fundoiano-Hershcovitz, Y., Asher, I. B., Kantor, H., Rahmon, S., Ritholz, M. D., Horwitz, D. L., Manejwala, O., & Goldstein, P. (2024). Walking away from depression: the mediating role of walking activity in depression impacting blood glucose levels of people with diabetes or prediabetes. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1446405
  7. YIFAT HERSHCOVITZ, MICHAL TAMIR, OMAR MANEJWALA; 708-P: Hypertension Control among People with Diabetes Using a Self-Management Multicondition Digital Platform. Diabetes 1 June 2022; 71 (Supplement_1): 708–P. https://doi.org/10.2337/db22-708-P
  8. YIFAT HERSHCOVITZ, INBAR BREUER ASHER, OMAR MANEJWALA; 1012-P: Deep Sleep Interaction with Blood Glucose Levels in People Using an Integrated Digital Health Platform for Diabetes Management. Diabetes 14 June 2024; 73 (Supplement_1): 1012–P. https://doi.org/10.2337/db24-1012-P